MorphoSys (NASDAQ:MOR – Get Free Report) and Graybug Vision (NASDAQ:GRAY – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, risk, institutional ownership, earnings, dividends and analyst recommendations. Valuation & Earnings This table compares MorphoSys and Graybug […]
Transaction to include felzartamab, a potential first-in-class therapeutic candidate with promise as a pipeline-in-a-product across a range of immune-mediated diseasesFelzartamab is an investigational.
Transaction to include felzartamab, a potential first-in-class therapeutic candidate with promise as a pipeline-in-a-product across a range of immune-mediated diseasesFelzartamab is an investigational
Human Immunology's drug is being developed for a kidney condition called primary membranous nephropathy and for complications after kidney transplants.
I-Mab Reports Full Year 2023 Financial Results and Business Update balticbusinessnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from balticbusinessnews.com Daily Mail and Mail on Sunday newspapers.